Elizabeth J McKinnon1, Enrico Rossi2, John P Beilby3, Debbie Trinder4, John K Olynyk5. 1. Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia. 2. PathWest, Perth, Western Australia, Australia. 3. PathWest, Perth, Western Australia, Australia; School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, Western Australia, Australia. 4. School of Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Fremantle, Western Australia, Australia; Western Australian Institute of Medical Research, Perth, Western Australia, Australia. 5. Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia; Department of Gastroenterology, Fremantle Hospital, Fremantle, Western Australia, Australia; Curtin Health Innovation Research Institute, Curtin University, Bentley, Western Australia, Australia. Electronic address: john.olynyk@health.wa.gov.au.
Abstract
BACKGROUND & AIMS: Serum levels of ferritin are commonly measured to assess iron stores but are affected by factors such as obesity and chronic disease. Published reference ranges have not changed in decades, and the number of patients whose levels exceed the upper limits has been increasing. As a result, more patients are evaluated for iron overload. METHODS: We compared serum levels of ferritin in 1188 Australian adults who participated in the 2005 Busselton Population Survey with levels from the 1995 survey. Parametric regression was used to assess the effects of body weight and biochemical parameters on serum level of ferritin to derive contemporary population-appropriate reference ranges. RESULTS: In 2005, age-adjusted levels of ferritin were 21% higher in men (P < .0001) and 10% higher in women (P = .01) than in 1995; 31% of men exceeded levels of 300 μg/L, compared with 23% in 1995. Body mass index (BMI) ≥25 kg/m(2) was associated with higher levels of ferritin in men ≥35 years old and in postmenopausal women (P ≤ .002). Serum level of γ-glutamyltransferase (GGT) correlated with serum level of ferritin (P < .0001). In men, the estimated 95th percentiles ranged from 353 to 495 μg/L (<35 years), from 350 to 511 μg/L (≥35 years, BMI <25 kg/m(2)), and from 413 to 696 μg/L (≥35 years, BMI ≥25 kg/m(2)) when GGT levels were 10-75 IU/L. In women, the 95th percentiles ranged from 106 to 235 μg/L (premenopausal), from 222 to 323 μg/L (postmenopausal, BMI <25 kg/m(2)), and from 249 to 422 μg/L (postmenopausal, BMI ≥25 kg/m(2)) when GGT levels were 8-45 IU/L. CONCLUSION: Serum levels of ferritin increased significantly between 1995 and 2005. Reference ranges that accommodate demographic and biomedical variations will assist clinicians in identifying individuals who require further evaluation for iron overload.
BACKGROUND & AIMS: Serum levels of ferritin are commonly measured to assess iron stores but are affected by factors such as obesity and chronic disease. Published reference ranges have not changed in decades, and the number of patients whose levels exceed the upper limits has been increasing. As a result, more patients are evaluated for iron overload. METHODS: We compared serum levels of ferritin in 1188 Australian adults who participated in the 2005 Busselton Population Survey with levels from the 1995 survey. Parametric regression was used to assess the effects of body weight and biochemical parameters on serum level of ferritin to derive contemporary population-appropriate reference ranges. RESULTS: In 2005, age-adjusted levels of ferritin were 21% higher in men (P < .0001) and 10% higher in women (P = .01) than in 1995; 31% of men exceeded levels of 300 μg/L, compared with 23% in 1995. Body mass index (BMI) ≥25 kg/m(2) was associated with higher levels of ferritin in men ≥35 years old and in postmenopausal women (P ≤ .002). Serum level of γ-glutamyltransferase (GGT) correlated with serum level of ferritin (P < .0001). In men, the estimated 95th percentiles ranged from 353 to 495 μg/L (<35 years), from 350 to 511 μg/L (≥35 years, BMI <25 kg/m(2)), and from 413 to 696 μg/L (≥35 years, BMI ≥25 kg/m(2)) when GGT levels were 10-75 IU/L. In women, the 95th percentiles ranged from 106 to 235 μg/L (premenopausal), from 222 to 323 μg/L (postmenopausal, BMI <25 kg/m(2)), and from 249 to 422 μg/L (postmenopausal, BMI ≥25 kg/m(2)) when GGT levels were 8-45 IU/L. CONCLUSION: Serum levels of ferritin increased significantly between 1995 and 2005. Reference ranges that accommodate demographic and biomedical variations will assist clinicians in identifying individuals who require further evaluation for iron overload.
Authors: Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten Journal: J Nutr Date: 2018-06-01 Impact factor: 4.798
Authors: A Dzedzej; W Ignatiuk; J Jaworska; T Grzywacz; P Lipińska; J Antosiewicz; A Korek; E Ziemann Journal: Biol Sport Date: 2016-05-10 Impact factor: 2.806
Authors: Zhenyuan Bian; Hie-Won Hann; Zhong Ye; Chun Yin; Yang Wang; Wan Fang; Shaogui Wan; Chun Wang; Kaishan Tao Journal: Oncol Lett Date: 2018-07-06 Impact factor: 2.967
Authors: Parminder S Suchdev; Anne M Williams; Zuguo Mei; Rafael Flores-Ayala; Sant-Rayn Pasricha; Lisa M Rogers; Sorrel Ml Namaste Journal: Am J Clin Nutr Date: 2017-10-25 Impact factor: 7.045